Vagus Nerve Stimulation Device For U.S. Adults Exploring Neurotech Available

Nuropod is available for U.S. adults exploring wearable vagus nerve stimulation as part of their approach to everyday stress and personal wellness.

Sacramento, United States, October 7, 2026 /PressCable/ -- U.S. adults interested in incorporating wearable neurotechnology into their daily routines can access Nuropod, a noninvasive vagus nerve stimulation device developed by Parasym. The device offers an at-home option for adult wellness amid everyday stress, delivering gentle electrical pulses through an earpiece during sessions.

More details can be found at https://nuropod.com/collections/products

The announcement comes as many U.S. adults continue to search for ways to manage stress and support recovery, with The American Institute of Stress, citing American Psychological Association research, reporting that 75-85% of adults experience physical or mental symptoms of stress. That connection between stress and physical experience brings the nervous system’s role in responding to daily pressures into focus.

Nuropod’s approach centers on stimulation of the vagus nerve, which carries signals between the brain and organs including the heart, lungs, and gut. The nerve plays a role in how the body handles stress, rest, and recovery.

The device applies stimulation at the tragus, the small section of the outer ear immediately in front of the ear canal. Its earpiece clips onto this location and delivers electrical pulses using Parasym’s proprietary AVNT™ waveform. Stimulation passes through the skin without surgery.

Parasym says the technology draws on more than a decade of research and development. Its neuromodulation technology has been investigated in randomized, placebo-controlled research, and the AVNT waveform is clinically tested. The company reports more than 60 completed clinical studies, over 100 ongoing studies, and more than 150 research partners within its research program.

The device’s format allows sessions to fit around familiar activities. “Most people use the device for around 30 minutes, once or twice a day, while working, reading or watching television,” the company explains. Sessions do not require a clinic visit.

Nuropod comes with the earpiece and charger needed for these sessions, alongside a Quick Start Guide for setup. A protective case keeps the equipment together for storage or travel.

About Nuropod

Nuropod is part of Parasym’s wearable neurotechnology offering for North America. The device is FCC compliant and comes with a 30-day return guarantee.

Further information about Nuropod is available at https://nuropod.com/collections/products

Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-significant risk device and is not intended to diagnose, treat, cure, or prevent any disease.

Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/

Source: PressCable

Release ID: 89205441

In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.